World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
67
Citations
16540
World Ranking
2878
National Ranking
276

Philip N. Patsalos publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Philip N. Patsalos sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 311 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Philip N. Patsalos D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Philip N. Patsalos sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 67 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Philip N. Patsalos is affiliated with University College London in the United Kingdom. Their research primarily focuses on the field of Medicine, with specific work in Psychiatry and Mental Health, Pediatrics, Perinatology and Child Health, Pharmacology, Infectious Diseases, and Oncology.

The scientist has contributed to various topics including epilepsy research and treatment, pharmacological effects and toxicity studies, drug transport and resistance mechanisms, cannabis and cannabinoid research, COVID-19 clinical research studies, antibiotics pharmacokinetics and efficacy, and SARS-CoV-2 and COVID-19 research.

Recent publications by Philip N. Patsalos include:

  • "Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs," 2020, Epilepsia
  • "Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects," 2020, Expert Opinion on Drug Metabolism & Toxicology
  • "Pharmacokinetic characterization of favipiravir in patients with COVID-19," 2022, British Journal of Clinical Pharmacology
  • "Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force," 2022, Epilepsia Open
  • "Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study," 2020, BMC Neurology

Frequent co-authors of Philip N. Patsalos include:

  • Cecilie Johannessen Landmark
  • Svein I. Johannessen
  • Jerzy P. Szaflarski
  • Barry E. Gidal
  • Kevan VanLandingham

The scientist's work is regularly published in several specialized venues, with multiple publications in Expert Opinion on Drug Metabolism & Toxicology, as well as contributions to Epilepsia, British Journal of Clinical Pharmacology, Epilepsia Open, and BMC Neurology.

Best Publications

  • Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

    Philip N. Patsalos;David J. Berry;Blaise F. D. Bourgeois;James C. Cloyd

  • Pharmacokinetic profile of levetiracetam: toward ideal characteristics.

    P.N. Patsalos

  • Clinical pharmacokinetics of levetiracetam

    Philip N. Patsalos

  • The Importance of Drug Interactions in Epilepsy Therapy

    Philip N. Patsalos;Walter Fröscher;Francesco Pisani;Clementina M. Van Rijn

  • Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs

    Philip N Patsalos;Emilio Perucca

  • Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

    Philip N Patsalos;Emilio Perucca

  • Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

    C.L.P. Deckers;S.J. Czuczwar;Y.A. Hekster;A.J.M. Keyser

  • Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update.

    Philip N Patsalos;Edgar P Spencer;Dave J Berry

  • Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study

    R Katzenschlager;A Evans;A Manson;P N Patsalos

  • Therapeutic drug monitoring of the newer antiepileptic drugs.

    Svein I. Johannessen;Dina Battino;David J. Berry;Meir Bialer

  • Drug interactions involving the new second- and third-generation antiepileptic drugs.

    Cecilie Johannessen Landmark;Philip N. Patsalos

  • The new generation of GABA enhancers. Potential in the treatment of epilepsy.

    Stanislaw J. Czuczwar;Philip N. Patsalos

  • Benzodiazepine Receptor Quantification in vivo in Humans Using [11C]Flumazenil and PET: Application of the Steady-State Principle:

    N. A. Lassen;P. A. Bartenstein;A. A. Lammertsma;M. C. Prevett

  • The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist.

    Philip N. Patsalos

  • Drug Interactions with the Newer Antiepileptic Drugs (AEDs)—Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs

    Philip N. Patsalos;Philip N. Patsalos

  • The excitatory amino acid antagonist d-CPP-ene (SDZ EAA-494) in patients with epilepsy

    S. Sveinbjornsdottir;J.W.A.S. Sander;D. Upton;P.J. Thompson

  • Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial.

    Alan W.C. Yuen;Josemir W. Sander;Dominique Fluegel;Philip N. Patsalos

  • Therapeutic drug monitoring of antiepileptic drugs by use of saliva.

    Philip N. Patsalos;Dave J. Berry

  • Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia

    Joanna M Zakrzewska;Philip N Patsalos

  • INVESTIGATION INTO THE ROLE OF N-ACETYLASPARTATE IN CEREBRAL OSMOREGULATION

    Deanna L. Taylor;Siân E. C. Davies;Tihomir P. Obrenovitch;Mary H. Doheny

  • A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED ADD-ON TRIAL OF LAMOTRIGINE IN PATIENTS WITH SEVERE EPILEPSY

    J.W.A.S. Sander;P.N. Patsalos;J.R. Oxley;M.J. Hamilton

  • Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia.

    J M Zakrzewska;P N Patsalos

  • Lamotrigine-induced carbamazepine toxicity: an interaction with carbamazepine-10,11 -epoxide

    T. Warner;P.N. Patsalos;M. Prevett;A.A. Elyas

  • Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies.

    Philip N. Patsalos

  • Clinical pharmacokinetics of new antiepileptic drugs.

    M.C. Walker;P.N. Patsalos

Frequent Co-Authors

Blaise F. D. Bourgeois
Blaise F. D. Bourgeois Boston Children's Hospital
Josemir W. Sander
Josemir W. Sander University College London
Simon Shorvon
Simon Shorvon University College London
John S. Duncan
John S. Duncan University College London
Matthew C. Walker
Matthew C. Walker University College London
Gail S. Bell
Gail S. Bell University College London
Graeme J. Sills
Graeme J. Sills University of Glasgow
John G. R. Jefferys
John G. R. Jefferys University of Oxford
Emilio Perucca
Emilio Perucca University of Pavia
Svein I. Johannessen
Svein I. Johannessen Oslo University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Neuroscience, several related online degree programs and professional pathways are worth considering. Many students pursue advanced studies in fields like social work, psychology, and behavioral analysis, which offer unique insights into the human mind and behavior.

For those focused on affordability, the most affordable online msw programs provide a path into mental health care and social services. These programs combine flexible study options with practical experience, opening doors for roles such as clinical social workers or case managers.

If you are interested in behavior analysis, there are bcba programs available online that train professionals to work with individuals experiencing behavioral challenges, including those on the autism spectrum.

Students seeking faster degree completion options will find value in online social work programs and accelerated psychology bachelor's degree programs. These allow you to pursue your interests in psychology or social work at a quicker pace.

Exploring these related degrees can broaden your career prospects, whether you wish to work in clinical practice, research, or community-based roles within the field of Neuroscience.

Best Scientists Citing Philip N. Patsalos

Trending Scientists

Recently Published Articles